single dose,single dose
Sponsors
International Bio Service, Siriraj Clinical Research Center
Conditions
Healthy volunteershealthy volunteer
Phase 1
Open Label, Randomized, Two-way Crossover, Two-sequence, Two-period, Two-treatment Study of Mosapride Tablet in Healthy Thai Volunteers
Active, not recruitingTCTR20161125001
Start: 2017-02-25Target: 36Updated: 2026-08-03
Open label, randomized, two-way crossover, two-sequence, two-period, two-treatment study of 750 mg levofloxacin tablet in healthy Thai volunteers
Active, not recruitingTCTR20161129005
Start: 2017-03-01Target: 28Updated: 2026-08-03
Open Label, Randomized, Two-way Crossover, Two-sequence, Two-period, Two-treatment Bioequivalence Study of 200 mg Voriconazole Film-coated Tablet Preparations in Healthy Thai Volunteers
Active, not recruitingTCTR20170124002
Start: 2017-01-04Target: 36Updated: 2026-08-03
An Open-label, Single-dose, Two-treatment, Two-period, Two-sequence, Randomized, Crossover Bioequivalence Study of 50 mg Cilostazol Tablets between Test and Reference Product (Pletaal® 50) in Healthy Thai Volunteers under Fasting Condition
Active, not recruitingTCTR20171128001
Start: 2018-01-15Target: 32Updated: 2026-08-03
An Open-label, Single-dose, Two-period, Two-treatment, Two-sequence, Randomized, Crossover Bioequivalence Study of 160 mg Valsartan Tablets between Test Product and Reference Product (Diovan® 160 mg) in Healthy Thai Volunteers under Fasting Condition
Active, not recruitingTCTR20171229005
Start: 2018-06-01Target: 60Updated: 2026-08-03
An Open-label, Single-dose, Two-treatment, Two-period, Two-sequence, Randomized, Crossover Bioequivalence Study of 300 mg Irbesartan Tablets between Test and Reference Product (Aprovel® 300 mg) in Healthy Thai Volunteers under Fasting Condition
Active, not recruitingTCTR20180831003
Start: 2018-10-02Target: 28Updated: 2026-08-03